Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Maine

16 recruiting clinical trials across 5 cities in Maine (ME). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
16
Total Trials
16
Recruiting Now
5
Cities
20
Conditions

Recruiting Trials in Maine

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT03754114

Brain Oxygen Optimization in Severe TBI, Phase 3

BOOST3 is a randomized clinical trial to determine the comparative effectiveness of two strategies for monitoring and treating patients with traumatic brain injury (TBI) in the...

Sponsor: University of MichiganEnrolling: 109420 locations
Brain Injuries, Traumatic
RECRUITINGPhase 1 / Phase 2NCT04094610

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies...

Sponsor: Turning Point Therapeutics, Inc.Enrolling: 7520 locations
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1
RECRUITINGNCT04682483

Cardiogenic Shock Working Group Registry

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock...

Sponsor: Tufts Medical CenterEnrolling: 500016 locations
Cardiogenic Shock
RECRUITINGPhase 2 / Phase 3NCT05076175

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative...

The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally...

Sponsor: Bristol-Myers SquibbEnrolling: 12020 locations
Colitis, Ulcerative
RECRUITINGPhase 2NCT05168930

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

This study is being done to test the effectiveness of zanubrutinib in combination with venetoclax in participants with previously treated chronic lymphocytic leukemia (CLL) or...

Sponsor: Dana-Farber Cancer InstituteEnrolling: 454 locations
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
RECRUITINGPhase 3NCT05848713

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

This is an international, open-label, stratified randomized controlled trial with Bayesian adaptive stopping rules to compare the effects of therapeutic-dose heparin vs. usual...

Sponsor: University of ManitobaEnrolling: 400020 locations
Community-acquired Pneumonia
RECRUITINGPhase 4NCT05916339

AWARE: Management of ADHD in Autism Spectrum Disorder

This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in...

Sponsor: Daniel CouryEnrolling: 50012 locations
ADHDAutism Spectrum Disorder
RECRUITINGNCT05929703

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care...

Sponsor: University of MichiganEnrolling: 19007 locations
DeliriumNeurocognitive DisordersMild Cognitive Impairment+7
RECRUITINGNCT06348238

Strategies to Improve Well-Being and Diabetes Management

This project aims to implement an adapted self-affirmation intervention among a population of individuals with diabetes to reduce the negative psychosocial impacts of stigma. In a...

Sponsor: Elizabeth ScharnetzkiEnrolling: 1501 location
Diabetes Mellitus, Type 2
RECRUITINGPhase 2NCT06635148

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA)...

The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in...

Sponsor: Janssen Research & Development, LLCEnrolling: 27420 locations
Geographic AtrophyMacular Degeneration
RECRUITINGPhase 3NCT06679101

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus...

The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negative status compared with DRd...

Sponsor: GlaxoSmithKlineEnrolling: 52020 locations
Multiple MyelomaNewly Diagnosed Multiple Myeloma
RECRUITINGPhase 3NCT06758401

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works...

The purpose of the study is to compare how the new combination treatment (Sigvotatug Vedotin plus pembrolizumab) works compared to pembrolizumab alone in patients with non-small...

Sponsor: PfizerEnrolling: 71420 locations
Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
RECRUITINGPhase 3NCT06824467

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard...

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 77020 locations
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
RECRUITINGPhase 2 / Phase 3NCT07063745

A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab...

The purpose of this study is to compare the clinical benefit of the combination of BMS-986504 (a selective MTA-cooperative inhibitor of PRMT5) plus pembrolizumab and chemotherapy...

Sponsor: Bristol-Myers SquibbEnrolling: 59020 locations
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
RECRUITINGNCT07228026

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma...

This study incorporates objectives directed at two subject cohorts: 1. Uncontrolled Adult and Pediatric Asthma Subjects: To demonstrate a statistically significant and clinically...

Sponsor: Biometry INCEnrolling: 16013 locations
Asthma
RECRUITINGPhase 2NCT07239336

Study of DONQ52 in Active Celiac Disease

The main aim is to see how DONQ52 works to improve small intestinal damage and reduce celiac-related symptoms due to gluten exposure, in participants with celiac disease (CeD)...

Sponsor: Chugai PharmaceuticalEnrolling: 9211 locations
Celiac Disease

Browse Trials by State

Frequently Asked Questions

There are currently 16 clinical trials actively recruiting participants in Maine. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Maine include Brain Injuries, Traumatic, Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors. Each has multiple active trials across research centers in the state.

Major trial sites in Maine include Portland, Scarborough, Westbrook, South Portland, Bangor. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.